EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Transcription Factors in the Pathogenesis of Schizophrenia

Ahmed M N Helaly iD, Ahmed Al-Emam iD

Life · 05.05.2026 · 16 (5) · 773

DOI: 10.3390/life16050773 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 05.05.2026. Verfasst von Ahmed M N Helaly und 1 weiteren Autor:innen. Beteiligte Einrichtung: Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt. Die Arbeit nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khaled University, King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophrenia (SCZ) is a severe neuropsychiatric disorder characterized by a progressive clinical course and associated with a wide range of gene transcription signatures. This review examined studies retrieved from PubMed (published between 2005 and 2025) that investigated transcription factors (TFs) correlated with SCZ. Approximately 150 studies aligning with the eligibility criteria were selected. The synthesized evidence identified more than 40 TFs implicated in the pathogenesis and risk of SCZ. Based on functionality, these TFs were categorized into four groups: (1) progenitor cell TFs (TCF4, POU3F2, NKX2.1, EGR3), (2) stem cell TFs (MYC, SOX2, ASCL1, REST, NR2E1), (3) metabolic reprogramming TFs (HIF1, SREBPs, STATs, SOX9, NRF1, NRF2, p53, FOXO, ATF4, NF-κB), and (4) nuclear TFs (AhR, RXR). The discussion shed light on how these TFs in consort with hundreds of potential genes could shape the pathophysiology of SCZ. Indeed, SCZ represents a complex genomic, nuclear, metabolic, and immune disorder characterized by a diseased cellular microenvironment, with hypoxia emerging as a key feature. Although targeting TFs pharmacologically remains challenging, innovative therapeutic strategies—such as antineoplastic and antipsychotic agents that modulate the cellular microenvironment—may offer promising new directions for SCZ treatment.

Schlagwörter

Stichwörter der Autor:innen

metabolic reprogrammingneurodevelopmentalnuclear receptorsschizophreniatranscription factors

Autor:innen und Institutionen

  • Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Department of Pathology, College of Medicine, King Khalid University, Asir 61421, Saudi Arabia.

ORCID-Profile: Ahmed M N Helaly, Ahmed Al-Emam

Förderung

  • King Khaled University
  • King Khalid University

Zitieren

APA

Helaly, A. M. N., & Al-Emam, A. (2026). Transcription Factors in the Pathogenesis of Schizophrenia. Life, 16(5), 773. https://doi.org/10.3390/life16050773

Vancouver

Helaly AMN, Al-Emam A. Transcription Factors in the Pathogenesis of Schizophrenia. Life. 2026;16(5):773. doi:10.3390/life16050773

BibTeX
@article{Helaly2026,
  author = {Helaly, Ahmed M N and Al-Emam, Ahmed},
  title = {Transcription Factors in the Pathogenesis of Schizophrenia},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {773},
  doi = {10.3390/life16050773}
}
Kostenlos starten →